Longitudinal analysis of mammary cancer multiplicity in chemoprevention studies

Anticancer Res. 2000 Jul-Aug;20(4):2281-7.

Abstract

Background: The effect of chemopreventive agents on cancer multiplicity is of primary interest in animal studies. The nature of data collected from chemoprevention studies may be analyzed by a longitudinal analysis of repeatedly measured cancer multiplicity data.

Methods: We determined the number of mammary cancers over the entire follow-up period for varying doses of two chemopreventive agents. Longitudinal analyses were performed to model the number of cancers over different time intervals.

Results: There was a significant increase in the number of cancers between six to seven weeks post-carcinogen administration in the control group. Varying patterns of cancer development were observed at different doses of chemopreventive agents including a delay in onset of tumor growth compared to the control group.

Conclusion: Longitudinal data analysis complements traditional analyses by providing detailed information regarding the effect of chemopreventive agents on the pattern of tumor development throughout the follow-up period. Importantly, some chemopreventive agents may delay time to appearance of mammary cancers without causing a significant difference in cancer multiplicity.

MeSH terms

  • Animals
  • Anticarcinogenic Agents / pharmacology*
  • Diterpenes
  • Female
  • Mammary Neoplasms, Experimental / pathology
  • Mammary Neoplasms, Experimental / prevention & control*
  • Rats
  • Rats, Sprague-Dawley
  • Retinyl Esters
  • Time Factors
  • Triazoles / pharmacology
  • Vitamin A / analogs & derivatives
  • Vitamin A / pharmacology

Substances

  • Anticarcinogenic Agents
  • Diterpenes
  • Retinyl Esters
  • Triazoles
  • Vitamin A
  • vorozole
  • anhydrovitamin A
  • retinol acetate